Get the Stockscreener App
4.06
1.25%
0.05
After Hours:
4.10
0.04
+0.99%
Cytek Biosciences Inc stock is traded at $4.06, with a volume of 438.01K.
It is up +1.25% in the last 24 hours and up +2.53% over the past month.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
See More
Previous Close:
$4.01
Open:
$4.04
24h Volume:
438.01K
Relative Volume:
0.45
Market Cap:
$516.53M
Revenue:
$193.01M
Net Income/Loss:
$-12.15M
P/E Ratio:
-45.11
EPS:
-0.09
Net Cash Flow:
$454.00K
1W Performance:
+4.10%
1M Performance:
+2.53%
6M Performance:
+9.14%
1Y Performance:
-23.97%
1-Day Range:
$4.01
$4.175
1-Week Range:
$3.75
$4.175
52-Week Range:
$2.37
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
Name
Cytek Biosciences Inc
Sector
Industry
Phone
(877) 922-9835
Address
47215 LAKEVIEW BOULEVARD, FREMONT
Compare CTKB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
4.06 | 510.17M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
129.45 | 231.95B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
97.71 | 142.60B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.75 | 141.45B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.34 | 123.83B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.93 | 43.07B | 5.69B | 1.41B | 577.90M | 6.9828 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-09-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-31-25 | Downgrade | Goldman | Buy → Sell |
| Dec-14-23 | Initiated | Stephens | Overweight |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
Cytek Biosciences Inc Stock (CTKB) Latest News
Cytek Biosciences relocates European HQ to Amsterdam’s life sciences district - TradingView
Cytek Biosciences Relocates European Headquarters to New Facility in Amsterdam - MarketScreener
Cytek Biosciences Relocates European Headquarters to Amsterdam, Expanding Operations and Customer Support - Quiver Quantitative
Cytek® Biosciences Expands European Presence with New - GlobeNewswire
40% Larger Footprint: Cytek Biosciences Opens Amsterdam EU HQ with Training Center & In‑House Warehouse - Stock Titan
Will Cytek Biosciences Inc. see short term momentum2025 Sector Review & Community Consensus Trade Alerts - newser.com
Cytek Biosciences, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Risk vs reward if holding onto Cytek Biosciences Inc.Market Performance Recap & AI Driven Stock Price Forecasts - newser.com
Long term hold vs stop loss in Cytek Biosciences Inc.Quarterly Market Review & Step-by-Step Trade Execution Guides - newser.com
How Cytek Biosciences Inc. stock reacts to inflationary pressures2025 Trading Volume Trends & Weekly High Potential Alerts - newser.com
Will Cytek Biosciences Inc. stock continue dividend increasesJuly 2025 Summary & Precise Swing Trade Entry Alerts - newser.com
How interest rate cuts could boost Cytek Biosciences Inc. stockMarket Growth Review & AI Driven Price Forecasts - newser.com
Cytek Biosciences' (CTKB) "Sell (E+)" Rating Reiterated at Weiss Ratings - MarketBeat
Using Python tools to backtest Cytek Biosciences Inc. strategies2025 Key Highlights & Smart Swing Trading Alerts - newser.com
Cytek Biosciences (NASDAQ:CTKB) Upgraded to Strong-Buy at Zacks Research - MarketBeat
Cytek Biosciences Inc 8EQ Stock Analysis and ForecastAutomated Trading Signals & Small Budget Capital Gains - earlytimes.in
Cytek Announces Global Reach in Sales of Flow Cytometry Systems | RapidScan | Jan/Feb 2020 - Photonics Spectra
Cytek Biosciences, Inc. $CTKB Shares Bought by Public Employees Retirement System of Ohio - Defense World
Should you wait for a breakout in Cytek Biosciences Inc.July 2025 Levels & Risk Adjusted Swing Trade Ideas - newser.com
Is Cytek Biosciences Inc. stock ready for a breakoutJuly 2025 Recap & Accurate Buy Signal Notifications - newser.com
Using data filters to optimize entry into Cytek Biosciences Inc.July 2025 Gainers & Free Safe Entry Trade Signal Reports - newser.com
How Cytek Biosciences Inc. stock performs in rising dollar environmentTrade Entry Report & Weekly Momentum Picks - newser.com
Cytek Extends its Flow Cytometry Capabilities | BioScan | Jan/Feb 2022 - Photonics Spectra
Cytek Biosciences (NASDAQ:CTKB) Trading Up 8.9%Here's Why - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Full technical analysis of Cytek Biosciences Inc. stockQuarterly Portfolio Review & AI Powered Trade Plan Recommendations - newser.com
Cytek Biosciences Inc Stock Analysis and ForecastEarnings Volatility Patterns & Fast Growing Investment Ideas - earlytimes.in
Cell Analyzer | Cytek Biosciences Inc. | May/Jun 2025 - Photonics Spectra
Cytek Announces Global Reach in Sales of Flow Cytometry Systems | RapidScan | Nov 2019 - Photonics Spectra
Cytek Biosciences Inc Stock (CTKB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.84%
2.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):